OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drop shows promise for glaucoma patients in large trial
Disease control CompletedThis study tested a new eye drop called Reformulated PG324 to see how well it lowers eye pressure in people with open-angle glaucoma or high eye pressure. About 489 adults took part. The goal was to measure the drop's safety and effectiveness in controlling eye pressure, which is…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Laser plus drops: a new combo for glaucoma?
Disease control CompletedThis study looked at 70 people with mild to moderate glaucoma or high eye pressure. All received a laser treatment called selective laser trabeculoplasty (SLT). Afterward, half used Rocklatan eye drops and half used artificial tears. The goal was to see if Rocklatan lowered eye p…
Matched conditions: OCULAR HYPERTENSION
Sponsor: Colorado Ophthalmology Associates PC • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New eye drop shows promise for glaucoma patients
Disease control CompletedThis study tested a new eye drop called SBI-100 in 56 adults with glaucoma or high eye pressure. Participants received either a low dose, high dose, or placebo drop twice daily for 14 days. Researchers measured how well the drops lowered eye pressure and checked for side effects.
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Which laser spot works best for glaucoma? small study tests two options
Disease control CompletedThis study tested two different laser treatment locations for open-angle glaucoma: one targeting the nasal side of the eye and one targeting the inferior side. 13 patients received the laser procedure to see which location better lowers eye pressure. The goal is to find the most …
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New Preservative-Free eye drops take on glaucoma in Head-to-Head trial
Disease control CompletedThis completed Phase 2 trial tested two strengths of a new eye drop called T4090 against the existing drug Rhopressa in 161 adults with open-angle glaucoma or ocular hypertension. The goal was to see which better lowers eye pressure over 7 weeks. Participants used one drop daily …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New eye drops aim to lower glaucoma pressure
Disease control CompletedThis phase 2 trial tested two new eye drop formulas, AR-17043 and PG043, in 426 people with open-angle glaucoma or ocular hypertension. The goal was to see if they safely lower eye pressure better than existing drops. Participants received different doses of the study drops or st…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New eye drop aims to beat standard glaucoma treatment
Disease control CompletedThis phase 3 trial tested whether a new eye drop called NCX 470 can lower eye pressure better than the standard drop latanoprost in people with open-angle glaucoma or ocular hypertension. About 696 participants used one drop in each eye every evening for up to 12 months. The stud…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Nicox Ophthalmics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:05 UTC
-
New implant tackles cataracts and glaucoma in one surgery
Disease control CompletedThis study tested a device that combines a bimatoprost implant with a special intraocular lens to treat both cataracts and glaucoma or high eye pressure. Twenty-four participants received the implant during cataract surgery. The main goals were to see if it lowers eye pressure an…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
New eye scan may spot glaucoma before vision loss begins
Diagnosis CompletedThis study tested whether a high-resolution eye scan called SD-OCT can diagnose glaucoma more accurately than standard methods. Researchers compared 109 people with and without glaucoma using the scan. The goal was to see if this technology could catch the disease earlier, before…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Smart contact lens could revolutionize glaucoma monitoring
Diagnosis CompletedThis study tested a new smart contact lens called miLens that records eye pressure patterns over 24 hours in 86 adults with glaucoma and healthy volunteers. Participants wore the lens in one eye and took smartphone readings every 15 minutes while awake. Researchers compared the l…
Matched conditions: OCULAR HYPERTENSION
Sponsor: Smartlens, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC